Jade Biosciences (JBIO) Change in Account Payables (2020 - 2026)
Jade Biosciences (JBIO) posted Change in Account Payables of $2.3 million for Q1 2026, up 673.42% on a QoQ basis from $301000.0 in Q4 2025, and down 13.04% year-over-year from $2.7 million in Q1 2025.
Jade Biosciences (JBIO) Change in Account Payables (2020 - 2026) Analysis & Trends
Jade Biosciences' Change in Account Payables history runs 7 years deep, the most recent figure standing at $2.3 million for Q1 2026.
- Quarterly Change in Account Payables fell 13.04% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12000.0 (down 99.77% YoY) and the FY2025 annual result came in at $361000.0, up 116.62% from the prior year.
- Change in Account Payables was $2.3 million for Q1 2026 at Jade Biosciences, up from $301000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.7 million in Q1 2025 and bottomed at -$4.9 million in Q3 2025.
- A 5-year average of $427294.1 and a median of $835000.0 in 2024 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2024 — Change in Account Payables soared 223.56% — and 2025, when it plunged 1736.91%.
- Jade Biosciences' Change in Account Payables stood at -$1.7 million in 2022, then surged by 40.31% to -$1.0 million in 2023, then surged by 223.56% to $1.3 million in 2024, then slumped by 76.67% to $301000.0 in 2025, then soared by 673.42% to $2.3 million in 2026.
- Business Quant data shows JBIO's Change in Account Payables at $2.3 million in Q1 2026, $301000.0 in Q4 2025, and -$4.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Jade Biosciences | 16.25 Mn | 16.25 Mn | - | 2.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.33 Mn |
| Mar 31, 2026 | 2.33 Mn |
| Dec 31, 2025 | 301,000.00 |
| Dec 31, 2025 | 301,000.00 |
| Sep 30, 2025 | -4.88 Mn |
| Sep 30, 2025 | -4.88 Mn |
| Jun 30, 2025 | 2.26 Mn |
| Jun 30, 2025 | 2.26 Mn |
| Mar 31, 2025 | 2.68 Mn |
| Mar 31, 2025 | 2.68 Mn |
| Dec 31, 2024 | 1.29 Mn |
| Dec 31, 2024 | 1.29 Mn |
| Sep 30, 2024 | 298,000.00 |
| Sep 30, 2024 | 298,000.00 |
| Jun 30, 2024 | 948,000.00 |
| Jun 30, 2024 | 948,000.00 |
| Mar 31, 2024 | 835,000.00 |
| Mar 31, 2024 | 835,000.00 |
| Dec 31, 2023 | -1.04 Mn |
| Dec 31, 2023 | -1.04 Mn |